About Mabthera (Rituximab)
Generic: Rituximab Injection
Type: Injection vial
Strength: MABTHERA 100 / 500 mg Injection
Packing: 10ml, 50ml Vial
MabThera is approved for the treatment of adults with the following blood cancers: previously untreated and relapsed or refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma, and previously untreated and previously treated chronic lymphocytic leukaemia.
South Delhi Pharma can facilitate the supply of “Mabthera (Rituximab)” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Mabthera (Rituximab) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Mabthera is?
Mabthera is used to treat certain types of cancer such as non-Hodgkin’s lymphoma, chronic lymphocytic leukemia and can decrease joint pain and decrease the swelling of the blood vessels.
What Rituximab is?
Rituximab, sold under the brand name Mabthera among others, is a medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein-Barr virus-positive mucocutaneous ulcers.It is given by slow injection into a vein.